A research team involving Adil Mardinoglu and Mathias Uhlén at KTH Royal Institute of Technology/SciLifeLab are planning a clinical trial of a new treatment for nonalcoholic fatty liver disease and type 2 diabetes. The treatment harnesses liver cells’ own ability to burn accumulated fats.
The team used a metabolic modeling approach, which relied on data from the Human Protein Atlasproject, which also involved a number of researchers connected to SciLifeLab. The study was was published in Molecular Systems Biology.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.